More on ELVN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+22.8% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Enliven Therapeutics, Inc (NQ:ELVN)
Delayed: 52.74 -0.21 (0.4%)
Prev. Close $52.95  
Open$53.41 
52 Wk High$ 
52 Wk Low$ 
Day High$55.79 
Day Low$52.54 
P/E N/A  
EPS$ 
Volume1,408,410 

Friends, Peers and Foes (?): ALLO, CHRS, ONCY, PYXS, MAZE (more...)

Jul 21, 2026 05:24 PM Form 4 Enliven Therapeutics, For: Jul 17 Filed by: Hohl Benjamin
Jul 21, 2026 05:23 PM Form 4 Enliven Therapeutics, For: Jul 17 Filed by: Collins Helen Louise
Jul 21, 2026 06:38 AM Enliven Therapeutics (ELVN) PT Raised to $67 at Goldman Sachs
Jul 17, 2026 04:37 PM Form 144 Enliven Therapeutics, Filed by: Collins Helen Louise
Jul 9, 2026 06:47 AM Enliven Therapeutics (ELVN) PT Raised to $65 at H.C. Wainwright
Jul 8, 2026 05:16 PM Form 4 Enliven Therapeutics, For: Jul 06 Filed by: Kunkel Lori Anne
Jul 1, 2026 08:23 AM Enliven Therapeutics (ELVN) PT Raised to $80 at Stifel
Jun 29, 2026 07:02 AM Enliven Therapeutics (ELVN) PT Raised to $70 at Jones Trading
Jun 24, 2026 07:20 PM Form 4 Enliven Therapeutics, For: Jun 22 Filed by: OrbiMed Genesis GP LLC
Jun 24, 2026 07:16 PM Form SCHEDULE 13D/A Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC
View All Articles

Entities mentioned with ELVN

View All Entities